Insmed Incorporated
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INSM and other ETFs, options, and stocks.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
CEOWilliam H. Lewis
CEOWilliam H. Lewis
Employees613
Employees613
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded1988
Founded1988
Employees613
Employees613
INSM Key Statistics
Market cap2.92B
Market cap2.92B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.22M
Average volume1.22M
High today—
High today—
Low today—
Low today—
Open price$21.08
Open price$21.08
Volume0.00
Volume0.00
52 Week high$28.94
52 Week high$28.94
52 Week low$16.41
52 Week low$16.41
Analyst ratings
100%
of 13 ratingsBuy
100%
Hold
0%
Sell
0%
INSM Earnings
-$1.09
-$0.73
-$0.36
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated-$1.02 per share
Estimated-$1.02 per share
ActualExpected Feb 16, Pre-Market
ActualExpected Feb 16, Pre-Market